Publication
HFE variants and the expression of iron-related proteins in breast cancer-associated lymphocytes and macrophages
| dc.contributor.author | Marques, Oriana | |
| dc.contributor.author | Rosa, Ana | |
| dc.contributor.author | Leite, Luciana | |
| dc.contributor.author | Faustino, Paula | |
| dc.contributor.author | Rêma, Alexandra | |
| dc.contributor.author | Martins da silva, Berta | |
| dc.contributor.author | Porto, Graça | |
| dc.contributor.author | Lopes, Carlos | |
| dc.date.accessioned | 2017-02-14T13:55:02Z | |
| dc.date.available | 2017-02-14T13:55:02Z | |
| dc.date.issued | 2016-12-27 | |
| dc.description | Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264664/ | pt_PT |
| dc.description.abstract | The association of HFE (High Iron FE) major variants with breast cancer risk and behavior has been a matter of discussion for a long time. However, their impact on the expression of iron-related proteins in the breast cancer tissue has never been addressed. In the present study, hepcidin, ferroportin 1, transferrin receptor 1 (TfR1), and ferritin expressions, as well as tissue iron deposition were evaluated in a collection of samples from breast cancers patients and analyzed according to the patients’ HFE genotype. Within the group of patients with invasive carcinoma, those carrying the p.Cys282Tyr variant in heterozygosity presented a higher expression of hepcidin in lymphocytes and macrophages than wild-type or p.His63Asp carriers. An increased expression of TfR1 was also observed in all the cell types analyzed but only in p.Cys282Tyr/p.His63Asp compound heterozygous patients. A differential impact of the two HFE variants was further noticed with the observation of a significantly higher percentage of p.Cys282Tyr heterozygous patients presenting tissue iron deposition in comparison to p.His63Asp heterozygous. In the present cohort, no significant associations were found between HFE variants and classical clinicopathological markers of breast cancer behavior and prognosis. Although limited by a low sampling size, our results provide a new possible explanation for the previously reported impact of HFE major variants on breast cancer progression, i.e., not by influencing systemic iron homeostasis but rather by differentially modulating the local cellular expression of iron-related proteins and tissue iron deposition. | pt_PT |
| dc.description.sponsorship | OM is a recipient of the PhD grant SFRH/BD/2011/78184 from Fundação para a Ciência e Tecnologia (FCT). The authors also acknowledge financial support from ICBAS/AI&NSUMIB and by national funds through FCT and Ministério da Educação e Ciência (MEC) and when applicable co-funded by FEDER funds within the partnership agreement PT2020 related with the research unit number 4293. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Cancer Microenviron. 2016 Dec;9(2-3):85-91. doi: 10.1007/s12307-016-0191-4. Epub 2016 Dec 27. | pt_PT |
| dc.identifier.doi | 10.1007/s12307-016-0191-4 | pt_PT |
| dc.identifier.issn | 1875-2292 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/4162 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Springer/International Cancer Microenvironment Society | pt_PT |
| dc.relation.publisherversion | http://link.springer.com/article/10.1007%2Fs12307-016-0191-4 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | pt_PT |
| dc.subject | Breast Cancer | pt_PT |
| dc.subject | HFE | pt_PT |
| dc.subject | High Iron FE | pt_PT |
| dc.subject | Iron | pt_PT |
| dc.subject | p.Cys282Tyr | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.subject | Cancro | pt_PT |
| dc.subject | Metabolismo do Ferro | pt_PT |
| dc.subject | Modificadores Genéticos | pt_PT |
| dc.subject | Hepcidina | pt_PT |
| dc.title | HFE variants and the expression of iron-related proteins in breast cancer-associated lymphocytes and macrophages | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 91 | pt_PT |
| oaire.citation.startPage | 85 | pt_PT |
| oaire.citation.title | Cancer Microenvironment | pt_PT |
| oaire.citation.volume | 9(2-3) | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |